News | November 05, 2010

NICOM System Found to be Effective at Diagnosing Acute Heart Failure

November 5, 2010 - A study performed by investigators from the Emergency Department of the Cleveland Clinic Foundation found that a noninvasive cardiac output monitor (NICOM) system is effective in identification of acute heart failure (AHF). The system, by Cheetah Medical, is also effective in differentiating AHF from other acute situations with similar clinical presentations. The study was published last week in the American Journal of Emergency Medicine.

In this study, the Cheetah NICOM Noninvasive Cardiac Output and Hemodynamic Monitoring System was able to distinguish heart failure patients from patients diagnosed with COPD, asthma and dyspnea for other reasons. The FDA-cleared, non-invasive bedside test utilizes a set of four sensors placed on the patient's chest or back. The system was used to monitor patients' hemodynamics around a change in patient position, also known as "orthostatic challenge." The system accurately differentiated between heart failure and other conditions.

"Acute heart failure affects 5.8 million Americans per year, with costs exceeding $33 billion,” said Rakesh Engineer, M.D., FACEP, discipline leader, emergency and undifferentiated care at the Cleveland Clinic Lerner College of Medicine and the study's primary investigator. “Clinical judgment, even when combined with our best biomarkers, produces a diagnostic accuracy of only 82.5 percent. Clearly, new methods to determine the etiology of shortness of breath in emergency patients are needed. This study illustrates the utility of NICOM Bioreactance Technology in differentiating acute heart failure from asthma and COPD.”

"Outcomes in patients presenting to the emergency department with acute shortness of breath are related to appropriate and timely therapy,” said W. Frank Peacock, M.D., FACEP, vice chair, Emergency Medicine Institute, Cleveland Clinic Foundation and the study's senior author. “When therapy is delayed or inappropriate, the acute mortality rate is increased. Our data suggest that an early and accurate heart failure diagnosis can be determined by measuring hemodynamic changes using NICOM Technology."

For more information: www.cheetah-medical.com

Related Content

Cardiovascular Risk Significantly Higher in Women With Fatty Liver Disease
News | Womens Healthcare| October 20, 2017
Nonalcoholic fatty liver disease (NAFLD) is associated with significantly higher risk of subsequent cardiovascular...
Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology
News | Advanced Visualization| October 20, 2017
October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B financin
Pregnancy-Related Heart Failure Strikes Black Women Twice as Often as Other Races
News | Womens Healthcare| October 19, 2017
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to...
The Role of Telomere Length in Cardiovascular Risk Assessment
Feature | Cardiac Diagnostics| October 19, 2017 | Nanette H. Bishopric, M.D., FACC, FAHA
A new area of DNA testing involving telomere length may enhance a patient’s cardiovascular disease risk stratificatio
Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
Videos | Cardiovascular Ultrasound| October 12, 2017
Sharon Mulvagh, M.D., FRCPC, FACC, FAHA, FASE, professor, Division of Cardiology, Department of Medicine, Dalhouse Un
SunTech Medical Receives Third-Party Validation of CT40 BP Spot-Check Device
News | Blood Pressure Monitor| October 11, 2017
October 11, 2017 — The CT40 spot-check device from SunTech Medical has received third-party validation for...
New Evaluation Sends Low-Risk ER Chest Pain Patients Home Sooner
News | Cardiac Diagnostics| October 10, 2017
A new evaluation to determine whether emergency room patients with chest pain can go home and follow up with their...
Majority of High-Risk Stroke Patients Not Being Screened for Common Risk Factors
News | Stroke| September 28, 2017
September 28, 2017 — New research revealed that on average, more than 75 percent of people aged 65 and older worldwid
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Overlay Init